Cited In for PMID: 39520850

Your saved search

Your RSS Feed

Year	Number of Results
2024	1
2025	2
2026	1

Results by year

Page 1

Safety Analysis of Co-Administration of Radiation Therapy with Enfortumab Vedotin Based Regimens in Metastatic Urothelial Carcinoma.

Seyedin SN, Harada GK, Garemanian E, Rafizadeh D, Kaakour D, Dwabe S, Rezazadeh A, Daneshvar M, Mar N. Seyedin SN, et al. Clin Genitourin Cancer. 2024 Dec;22(6):102243. doi: 10.1016/j.clgc.2024.102243. Epub 2024 Oct 18. Clin Genitourin Cancer. 2024. PMID: 39520850 Free article.

Safety of Combining Radiation Therapy and Antibody Drug Conjugates in Advanced Urothelial and Other Cancers.

Lock D, Soni YS, Hwang L, Cole S, D'Souza A, Garant A, Yang DX, Arafat W, Zhang T, Ballas LK, Desai NB. Lock D, et al. Adv Radiat Oncol. 2025 Oct 22;11(1):101926. doi: 10.1016/j.adro.2025.101926. eCollection 2026 Jan. Adv Radiat Oncol. 2025. PMID: 41362410 Free PMC article.

A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma.

Urabe F, Sakanaka K, Nakata M, Goto Y, Muramoto K, Kadena S, Onuma H, Iwatani K, Imai Y, Tashiro K, Kimura T, Shimomura T. Urabe F, et al. Int Cancer Conf J. 2025 Jan 23;14(2):143-146. doi: 10.1007/s13691-025-00749-y. eCollection 2025 Apr. Int Cancer Conf J. 2025. PMID: 40160871 Free PMC article.

Page of 1

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 39520850

3 results

Results by year